Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
MPM BioImpact invests in private and public companies across the drug development process to transform scientific breakthroughs into life-saving medicines. The firm has supported the creation of companies like Orna Therapeutics, Aktis Oncology, and Reunion, which focus on circular RNA medicines, alpha radiopharmaceuticals, and next-generation psychedelic-inspired compounds, respectively.
Parse Score
Sources
openvc.app shapes more of what AI says about MPM BioImpact than any other source, at 33% of its citations.
basetemplates.com · linkedin.com · reuters.com · superscout.co